Live Breaking News & Updates on Medicines Evaluation Unit

Stay updated with breaking news from Medicines evaluation unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD

EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , Schleswig Holstein , Henrik Watz , Dennis Riedl , Dave Singh , Maria Bech , Ginny Norris , Pulmonary Research Institute , Epiendo Pharmaceuticals , University Of Manchester , World Economic Forum , Endo Pharmaceuticals , Chronic Obstructive Pulmonary Disease , Principal Investigators , Professor Dave Singh , Respiratory Pharmacology , Medical Director , Medicines Evaluation Unit , Professor Henrik Watz , Lungen Clinic , Chief Medical Officer , Chief Executive Officer , Global Economic Burden , Toyne Sewell Katie Duffell Feaven Abidta ,

EpiEndo reports Phase 2A results for lead asset, EP395, in COPD

REYKJAVIK, Iceland, April 10, 2024 EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral, barrier-enhancing, anti-inflammatory therapeutics addressing chronic airway diseases, announces the successful completion of its Phase 2A clinical trial for EP395 in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). ....

United Kingdom , Schleswig Holstein , Ginny Norris , Maria Bech , Dave Singh , Henrik Watz , Epiendo Pharmaceuticals , University Of Manchester , World Economic Forum , Pulmonary Research Institute , Chronic Obstructive Pulmonary Disease , Principal Investigators , Professor Dave Singh , Respiratory Pharmacology , Medical Director , Medicines Evaluation Unit , Professor Henrik Watz , Lungen Clinic , Chief Medical Officer , Chief Executive Officer , Global Economic Burden , Endo Pharmaceuticals , Katie Duffell ,

Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update

/PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug. ....

United States , United Kingdom , City Of , Jenene Thomas , Walter Klemp , Wolframcm Dempke , Department Of Registration Medicinal Products , Moleculin Biotech Inc , Drug Administration , Riverside Ethics Committee , Riverside Research Ethics Committee , Exchange Commission , Securities Exchange , Prnewswire Moleculin Biotech Inc , Ethics Committee , Healthcare Products Regulatory Agency , Polish Department , Medicinal Products , European Chief Medical Officer , Generation Anthracycline , Fast Track Status , Orphan Drug Designation , Commence Phase , Glycosylation Inhibitor , Glioblastoma Multiforme , Medicines Evaluation Unit ,

Moleculin Reports Full Year Financial Results and Provides Programs Update

– Preliminary positive safety and efficacy data from second Phase 1 AML study supports plans to explore a Phase 1/2 of Annamycin in combination with Cytarabine. ....

United States , United Kingdom , City Of , Jenene Thomas , Walter Klemp , Moleculin Biotech Inc , Company Investigational New Drug , Drug Administration , Riverside Ethics Committee , Riverside Research Ethics Committee , Exchange Commission , Prnewswire Moleculin Biotech Inc , Securities Exchange , Healthcare Products Regulatory Agency , Acute Myeloid Leukemia , Soft Tissue Sarcoma , Joy Yan , Recommended Phase , Investigational New Drug , Generation Anthracycline , Fast Track Status , Orphan Drug Designation , Initiate Phase , Complete Phase , Glycosylation Inhibitor , Medicines Evaluation Unit ,

Moleculin receives MHRA approval for Phase Ia trial of Covid-19 drug

Moleculin receives MHRA approval for Phase Ia trial of Covid-19 drug
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Walter Klemp , Riverside Research Ethics Committee , Healthcare Products Regulatory Agency , Moleculin Biotech , Medicines Evaluation Unit ,